ARCHIVES

Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985